5.00 (-1.22%)
As of Nov 06, 2023
Source:
Vaccitech Plc is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases, cancer, and autoimmunity. We aim to treat and prevent infectious diseases and cancer by using our proprietary platforms to develop product candidates that stimulate powerful, targeted immune responses against pathogens, infected cells, and tumor cells.
Country | United States |
Headquarters | didcot |
Phone Number | 44 (0) 1865 818808 |
Industry | |
CEO | William Enright |
Website | www.vaccitech.co.uk |